WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Week 13 Myasthenia Gravis, Black mamba secrete dendroxin Increase Acetylcholine input, Muscarinic Receptor Acute (Minutes -24 hours) Gastric Cramps, Atropinization Endpoints signs Clear Chest, Cholinergic Syndrome If certain of OP Poisoning Oximes (Nicotinic Effect Treatment), Blocks Acetylcholine formation and release Symptoms Difficulty swallowing, Acetylcholine-affecting disorders and substances Sarin gas (Nerve gas) Blocks Sodium Channels, Central Receptors Acute (Minutes-24 hours) Convulsions, Pulse rate increase by 25 per minute suggests mild or no toxicity for OPs, Muscle weakness for 1 month Correlates with Experiences severe muscle fatigue & weakness (Chronic), Atropine Test inject 0.6-1 mg IV, Cholinergic Syndrome Cascade of Symptoms Late (beyond 2 weeks), Oximes (Nicotinic Effect Treatment) Option 1 Pralidoxime, Patient: 20 yo F Weight: 110lbs (50kg) Height: 5'6 Maintenance dose Neostigmine (Prostigmin 15mg) 0.5mg/kg, Muscarinic Receptor Acute (Minutes -24 hours) Hypotension, DUMBELS Symptoms Lacrimation, Non-depolarizing/Depolarizing Nondepolarizing d-Tubocurarine, Acetylcholine-affecting disorders and substances Snake venom Cobra (Cobratoxin), Acetylcholine-affecting disorders and substances Neuromuscular Blockers Non-depolarizing/Depolarizing, ACh Receptors Causes Muscle Paralysis (Lack of contraction), Pancuronium block Acetylcholine receptors